These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 35060389)
1. Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy. Held C; Hadziosmanovic N; Aylward PE; Hagström E; Hochman JS; Stewart RAH; White HD; Wallentin L J Am Heart Assoc; 2022 Feb; 11(3):e023667. PubMed ID: 35060389 [TBL] [Abstract][Full Text] [Related]
2. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. Held C; White HD; Stewart RAH; Budaj A; Cannon CP; Hochman JS; Koenig W; Siegbahn A; Steg PG; Soffer J; Weaver WD; Östlund O; Wallentin L; J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066452 [TBL] [Abstract][Full Text] [Related]
4. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study. Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997 [TBL] [Abstract][Full Text] [Related]
5. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease. Lindholm D; Lindbäck J; Armstrong PW; Budaj A; Cannon CP; Granger CB; Hagström E; Held C; Koenig W; Östlund O; Stewart RAH; Soffer J; White HD; de Winter RJ; Steg PG; Siegbahn A; Kleber ME; Dressel A; Grammer TB; März W; Wallentin L J Am Coll Cardiol; 2017 Aug; 70(7):813-826. PubMed ID: 28797349 [TBL] [Abstract][Full Text] [Related]
6. Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy. Hilvo M; Wallentin L; Ghukasyan Lakic T; Held C; Kauhanen D; Jylhä A; Lindbäck J; Siegbahn A; Granger CB; Koenig W; Stewart RAH; White H; Laaksonen R; J Am Heart Assoc; 2020 May; 9(10):e015258. PubMed ID: 32375553 [TBL] [Abstract][Full Text] [Related]
7. Obesity and Serial NT-proBNP Levels in Guided Medical Therapy for Heart Failure With Reduced Ejection Fraction: Insights From the GUIDE-IT Trial. Parcha V; Patel N; Kalra R; Suri SS; Arora G; Wang TJ; Arora P J Am Heart Assoc; 2021 Apr; 10(7):e018689. PubMed ID: 33754794 [TBL] [Abstract][Full Text] [Related]
8. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908 [TBL] [Abstract][Full Text] [Related]
9. Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease. Vedin O; Hagström E; Östlund O; Avezum A; Budaj A; Flather MD; Harrington RA; Koenig W; Soffer J; Siegbahn A; Steg PG; Stewart RAH; Wallentin L; White HD; Held C; Int J Cardiol; 2017 Oct; 245():271-276. PubMed ID: 28735759 [TBL] [Abstract][Full Text] [Related]
10. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400 [TBL] [Abstract][Full Text] [Related]
11. Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study. Wallentin L; Eriksson N; Olszowka M; Grammer TB; Hagström E; Held C; Kleber ME; Koenig W; März W; Stewart RAH; White HD; Åberg M; Siegbahn A PLoS Med; 2021 Jan; 18(1):e1003513. PubMed ID: 33439866 [TBL] [Abstract][Full Text] [Related]
12. NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index Categories. Vergaro G; Gentile F; Meems LMG; Aimo A; Januzzi JL; Richards AM; Lam CSP; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; de Boer RA; Emdin M JACC Heart Fail; 2021 Sep; 9(9):653-663. PubMed ID: 34246607 [TBL] [Abstract][Full Text] [Related]
13. The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease: The Heart and Soul Study. Mishra RK; Judson G; Christenson RH; DeFilippi C; Wu AHB; Whooley MA Cardiology; 2017; 137(4):201-206. PubMed ID: 28445886 [TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560 [TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction]. Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276 [No Abstract] [Full Text] [Related]
16. Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome. Aimo A; Januzzi JL; Vergaro G; Clerico A; Latini R; Meessen J; Anand IS; Cohn JN; Gravning J; Ueland T; Nymo SH; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; de Boer RA; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Tentzeris I; Ripoli A; Passino C; Emdin M Eur J Prev Cardiol; 2019 Nov; 26(16):1751-1759. PubMed ID: 31154828 [TBL] [Abstract][Full Text] [Related]
17. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Rothenbacher D; Koenig W; Brenner H Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583 [TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF. Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249 [TBL] [Abstract][Full Text] [Related]